Lenacapavir, which protects people from H.I.V. infection with twice-yearly shots, is arriving in a country where the health system has been hollowed out by American aid cuts.
Go to Source
Author: Stephanie Nolen and Arlette Bashizi
https://rss.nytimes.com/services/xml/rss/nyt/HomePage.xml

